Viridos

Viridos is a privately held biotechnology company harnessing the power of photosynthesis to create transformative solutions to mitigate climate change. Our unparalleled understanding of algal genetics and ability to translate innovation from lab to field underpins our initial deployment: a scalable platform to produce low-carbon intensity biofuels for aviation, commercial trucking, and maritime shipping. Building on a legacy of genomic firsts, our team of scientists and engineers are shaping new pathways toward a sustainable bioeconomy. To learn more, visit us at Viridos.com.

Research San Diego, United States ~34 employees

Work at Viridos in HR or recruiting? Claim this page

Employees
34
0% in the 3 months to Sep 2026
Revenue / employee
$1.3M
Revenue ~$45M
Total funding
$155M
Last round Series A, Mar 2023
12-month attrition
16.3%
Tech: 0%
H1B filings, FY2024
1
Sponsors visas

Headcount trend

Viridos went from 48 employees in Oct 2024 to 34 in Sep 2026.

Funding rounds

Total funding$155M
Funding rounds5
Investors7
DateRoundMoney raisedNo.Investors
Mar 2023Series A$25M2
Mar 2023Funding$5M2
Sep 2019Series A$25M3
Sep 2015Funding$50M1
Apr 2014Funding$50M1

Org structure

Headcount by department

Other22
Finance5
Operations5
HR1
Design1

Viridos FAQ

How many employees does Viridos have?

Viridos has about 34 employees, unchanged over the 3 months to Sep 2026.

Does Viridos sponsor H1B visas?

Yes. Viridos filed 1 H1B (LCA) application in FY2024, according to the latest U.S. Department of Labor disclosures. It was for a Engineering role.

What is Viridos's revenue per employee?

Viridos makes about $1.32M in revenue per employee, based on $45M annual revenue and 34 employees.

How much funding has Viridos raised?

Viridos has raised $155M in total funding; its latest round was Series A in Mar 2023.

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.